Theophylline belongs to a class of drugs known as methylxanthines, which also includes caffeine and theobromine. In addition to its bronchodilator properties, theophylline has anti-inflammatory effects and can enhance the clearance of mucus in the lungs. This makes it a valuable choice for managing chronic respiratory issues in dogs. However, its therapeutic window is relatively narrow, meaning that the difference between an effective dose and a toxic dose can be small. This is particularly important to consider when discussing side effects.
Moreover, the market for pharma intermediates is rapidly evolving
. With the increasing demand for innovative therapies and a growing emphasis on personalized medicine, pharmaceutical manufacturers are investing in the research and development of new intermediates. This includes exploring alternative synthesis methods, such as green chemistry, which seeks to minimize environmental impact while maintaining efficiency in production.
pharma intermediates